Clinical trials
Hospitalized Children clinical trials
Below are recruiting hospitalized children clinical trials, each written for real people, not researchers. We’re tracking 1,227 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06506461RecruitingPhase 1
Gene editing for sickle cell disease in young adults
This trial uses gene editing to fix your own blood stem cells, so you can stop having severe sickle cell crises. It is for young adults with frequent pain episodes or who need regular blood transfusions.
Memphis, TennesseeAges 18–24 - NCT06525753Recruiting
Weaning from IV nutrition in children with intestinal failure
This study looks at children who have stopped needing IV nutrition (parenteral nutrition) for at least a year after having intestinal failure. It aims to understand their long-term health and growth.
Toronto, OntarioAges birth–18 years - NCT06560606Recruiting
Personalized medicine for childhood arthritis
This study creates a personalized medicine network to better understand and treat childhood arthritis. If you have JIA or unexplained joint inflammation, researchers will look at your biology to find the best treatment approach for you.
Calgary, AlbertaAges Up to 18 years - NCT06563726Recruiting
Sodium awareness study for breastfeeding moms of preemies
This study looks at whether tracking sodium levels in breast milk can help mothers of preterm babies improve their milk supply. If you are a new mom who gave birth before 35 weeks and plan to pump for at least two weeks, this trial may help you learn more about your milk.
Seattle, WashingtonAges Any age - NCT06579469Recruiting
Study of later effects of CAR T cell therapy
This study follows children and young adults who received CAR T cell therapy to understand any long-term side effects that may appear months to years later. By joining, you help researchers learn how to better care for patients after this treatment.
Aurora, ColoradoAges Up to 30 years - NCT06646640Recruiting
Long-term follow-up for hemoglobin disorder treatments
This study tracks people with sickle cell disease or thalassemia who have had a bone marrow transplant or gene therapy in the past 15 years. It aims to monitor their health over time to understand long-term effects.
Memphis, TennesseeAges Any age - NCT07085325Recruiting
Long-term follow-up study for medulloblastoma survivors treated with radiation
This study looks at the long-term health of people who were treated for medulloblastoma with craniospinal radiation at St. Jude Children's Research Hospital. It aims to understand how they are doing years after treatment.
Memphis, TennesseeAges Any age - NCT06777979RecruitingPhase 1
CAR T cell therapy for children with hard-to-treat leukemia
This trial tests a special kind of immune cell therapy that targets two markers (CD19 and CD22) on leukemia cells. It is for children and teens whose leukemia has come back multiple times or has not responded to standard treatment.
Memphis, TennesseeAges Up to 21 years - NCT06819475Recruiting
Muscle health study for childhood leukemia survivors
This study uses imaging to look at how well the mitochondria (the tiny power plants inside your muscle cells) are working. It compares survivors of childhood leukemia who have low muscle mass to healthy volunteers, to understand muscle health and find ways to help.
Memphis, TennesseeAges 18 years+ - NCT06847269RecruitingPhase 2
CAR T cell therapy for children and young adults with CD19+ leukemia
This trial tests an immunotherapy called CAR T cells for leukemia that has come back or is hard to treat. It aims to use your own immune cells to fight the cancer.
Memphis, TennesseeAges Up to 21 years - NCT06870981Recruiting
Optimizing nutrition and milk in infants (Opti-NuM)
This study looks at stored information and samples from babies who were part of earlier MaxiMoM nutrition trials. It aims to learn more about how nutrition and milk feeding affect infant health.
Palo Alto, CaliforniaAges 1 hour–3 weeks - NCT06902688Recruiting
Pharmacogenetic testing for kids at SickKids
This trial offers pharmacogenetic testing to children admitted to The Hospital for Sick Children to help doctors choose safer, more effective medications based on their genes.
Toronto, OntarioAges 6 months–18 years - NCT06993688Recruiting
How teens and families want to hear cancer news
This study looks at how teens and young adults with tough-to-treat cancers, and their families, want to hear news about their cancer. It will help doctors learn the best ways to share information during check-ups and scans.
Memphis, TennesseeAges 12 years+ - NCT07048535Recruiting
Long-term follow-up study for CAR T-cell therapy patients
This study follows children and young adults who received CAR T-cell therapy for B-cell ALL at least two years ago. It checks long-term side effects, how well the therapy worked over time, and quality of life, so doctors can better understand the lasting impacts of CAR T-cells.
Memphis, TennesseeAges Any age - NCT07052370RecruitingPhase 1
New stem cell transplant for children with high-risk blood cancer
This trial tests a special stem cell transplant from a half-matched family donor, designed to reduce rejection and infection risk. It may include a targeted drug (blinatumomab) to help kill remaining cancer cells.
Memphis, TennesseeAges Up to 21 years - NCT07069504Recruiting
Ai vs peer role-play for consent training in endoscopy
This trial compares two ways to train doctors in getting informed consent for endoscopy procedures: one uses an AI role-play and the other uses a peer role-play. It aims to find which method helps trainees learn better.
Toronto, OntarioAges 18 years+ - NCT07160621Recruiting
Pain management app for teen cancer survivors
This trial tests a culturally adapted mobile app to help teen cancer survivors manage chronic pain and improve daily functioning. It compares the app to standard care to see if it reduces pain interference.
Memphis, TennesseeAges 10–17 - NCT07195032RecruitingPhase 4
MMR vaccine safety in kids after heart transplant
This trial tests whether the MMR (measles, mumps, rubella) vaccine is safe and works well for children who have had a heart transplant. It may help protect you from these diseases if you haven't had the vaccine or no longer have immunity.
Kansas City, MissouriAges 1–17 - NCT07222345Recruiting
High-intensity interval training for Hodgkin lymphoma survivors
This study tests if a high-intensity interval training (HIIT) program is safe and doable for young people who have finished treatment for Hodgkin lymphoma. It might help you regain fitness and strength after recovery.
Memphis, TennesseeAges 10–25 - NCT07222735RecruitingPhase 1
CAR T cells and radiation for children with sarcoma
This trial tests a combination of targeted radiation and special immune cells (CAR T cells) for children and young adults whose bone or soft tissue sarcoma has come back or not responded to standard treatments. The CAR T cells are made from your own blood cells and are designed to attack a protein called B7-H3 found on the sarcoma cells.
Memphis, TennesseeAges Up to 21 years - NCT07228741RecruitingPhase 2
Exercise and medicine for heart health in ALL survivors with obesity
This trial tests if combining resistance exercise with the weight-loss medication tirzepatide can improve heart and metabolic health in survivors of childhood acute lymphoblastic leukemia (ALL) who are now adults and have obesity or overweight with related health issues. You may benefit if you finished treatment at least 2 years ago and meet weight and health criteria.
Memphis, TennesseeAges 18 years+ - NCT07245420Recruiting
Heart health study for childhood cancer survivors
This study checks heart health in adult survivors of childhood cancer who had certain heart-related treatments years ago. If you haven't had a heart ultrasound in the last 5 years, you may be able to help researchers learn how to better monitor heart health.
Memphis, TennesseeAges 26 years+ - NCT07392216Recruiting
Ovarian health in young women with sickle cell disease
This study looks at how sickle cell disease might affect the ovaries (the organs that store eggs) in girls and young women. It compares participants with sickle cell disease to healthy females of similar age and background.
Memphis, TennesseeAges 10–18 - NCT01605266Recruiting
Study of insights in children with nephrotic syndrome
This study looks at children’s experiences and understanding of nephrotic syndrome using questionnaires. It aims to learn what helps families and children, which could improve care over time.
Brampton, OntarioAges 6 months–18 years
Hear when a new Hospitalized Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalized children?
- Yes. Clin2 currently lists 1,227 recruiting hospitalized children studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalized children trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalized children trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.